STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI

The Story At A Glance

• • Federal agencies like HHS and the FDA are holding closed door meetings to establish standards for clinical AI.


• • Participants include tech companies, lobbyists, and academics under Chatham House Rules to prevent attribution.


• • The initiative aims to shape the governance and validation of AI systems used in medical settings.

Context
Federal regulators are moving to accelerate the integration of generative AI into healthcare through standardized oversight. This follows previous FDA efforts to monitor the performance of digital health devices.

Christian Perspective
The use of AI in medicine must respect the biological reality of the human person and the sanctity of life. We must ensure these algorithms do not promote a dehumanized view of patients or facilitate the termination of life through automated clinical decisions. Reliance on machine logic must never supersede the moral responsibility of the physician.

Implications
Closed door meetings between lobbyists and regulators threaten to prioritize corporate profit over the health of the American family. If AI standards are set in secret, they may be designed to bypass traditional medical ethics in favor of efficiency. This could lead to a healthcare system that treats humans as mere data points rather than children of God.

Broader Trends
This represents a push toward a technocratic governance model where unelected experts and globalist interests dictate the terms of human life and health. It mirrors the broader trend of moving decision making power away from local communities and into the hands of a centralized, unaccountable bureaucracy. Such centralization is a hallmark of